To determine whether the apoA-I mimetic peptide D-4F could inhibit tumour development, D-4F or a vehicle was administered daily until the first tumours were detectable, and, then, they were administered three times per week until the mice reached 19 weeks of age. Here, APOA1 is linked to neoplasm.